| Market Cap | ₹900Cr |
| ROE | 18.34% |
| P/E Ratio(TTM) | 31.13 |
| EPS(TTM) | 61.21 |
| P/B Ratio | 5.71 |
| Dividend Yield | 0.04% |
| Industry P/E | 40.28 |
| Book Value | 333.71 |
| Debt to Equity | 1.08 |
| Face Value | 10 |
| Parent Organisation | Fredun Pharmaceuticals Ltd |
| Managing Director | Mr. Fredun Medhora |
| BSE Symbol | 539730 |
| COMPANY | 52 WEEK | MARKET PRICE | P/E Ratio | |
|---|---|---|---|---|
| Torrent Pharmaceuticals | NA (0.00%) | 58.99 | ||
| Ajanta Pharma | NA (0.00%) | 32.29 | ||
| Gland Pharma | NA (0.00%) | 36.94 | ||
| Eris Lifesciences | NA (0.00%) | 48.78 |